| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/26/2008 | WO2007074391A3 Preparation of a key intermediate in the synthesis of rosuvastatin |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153859 5-{[6-Fluoro-2,5-dihydroxy-4,4,7-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-isoquinolin-1(2H)-one; anti-allergic, immunosuppressive and antiproliferative action |
| 06/26/2008 | US20080153852 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders |
| 06/26/2008 | US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | DE102007023102A1 Bisoxime als Fungizide Bisoximes as fungicides |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2672668A1 4-amino-1h-pyrimidin-2-one-based compounds, compositions comprising them and methods of their use |
| 06/26/2008 | CA2671414A1 Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | CN101208310A New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 06/25/2008 | CN101208309A Chloro-substituted guanidines |
| 06/25/2008 | CN101208308A 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 06/25/2008 | CN101208307A Process for preparing amorphous rosuvastatin calcium free of impurities |
| 06/25/2008 | CN101205215A Method for preparing cidofovir key intermediate |
| 06/25/2008 | CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390835 Aralkyl amines as cannabinoid receptor modulators |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390818 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390814 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments |
| 06/24/2008 | US7390806 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | WO2008073928A1 Composition for treating a pulmonary hypertension |
| 06/19/2008 | WO2008073687A2 Compounds and compositions as protein kinase inhibitors |
| 06/19/2008 | WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | WO2008073365A1 Aspartyl protease inhibitors |
| 06/19/2008 | WO2008073125A1 Moxonidine analogs, preparation processes and uses therefor |
| 06/19/2008 | WO2008072078A1 An improved process for preparing rosuvastatin caclium |
| 06/19/2008 | WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146600 potent proline transporter inhibitors such as (S)-2-(4-((3'-chlorobiphenyl-4-yl)(hydroxy)methyl)piperidin-1-yl)pyrimidin-5-ol, used as cognition activators or for treatment of brain disorders |
| 06/19/2008 | US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals |
| 06/19/2008 | US20080146597 Therapeutic Tetrahydroisoquinoline-Based Compositions for Cancer Therapy |
| 06/19/2008 | US20080146594 Thrombopoietin activity modulating compounds and methods |
| 06/19/2008 | US20080146574 Heterocycle Substituted Carboxylic Acids |
| 06/19/2008 | US20080146571 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 06/19/2008 | US20080146570 Chemical Compounds |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080146562 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 06/19/2008 | US20080145453 4-(piperimidine-2thione)phenyl derivatives; kinesin Eg5 inhibitor; anticarcinogenic agent; the aldehyde, the ketone and the thiourea are reacted together in the solid phase, grafted onto resin by esterification, and detached by hydrolysis |
| 06/19/2008 | US20080142759 For irradiation with blue/red laser; write only read many (WORM); digital versatile discs |
| 06/19/2008 | CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | CA2672293A1 Aspartyl protease inhibitors |
| 06/19/2008 | CA2669536A1 Composition for treating a pulmonary hypertension |
| 06/18/2008 | EP1931643A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 06/18/2008 | EP1931642A2 Novel pyrimidine carboxamides |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/18/2008 | CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/18/2008 | CN101203496A Process for preparing pure amorphous rosuvastatin calcium |
| 06/18/2008 | CN101200451A Method for preparing hydrochloride urapidil |
| 06/18/2008 | CN100395293C Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 06/18/2008 | CN100395246C Method for producing folic acid antagonist and its intermediate |
| 06/17/2008 | US7388014 Quinazoline derivatives and therapeutic use thereof |
| 06/17/2008 | CA2384188C Antiviral compositions |
| 06/17/2008 | CA2356380C Immunosuppressive effects of pteridine derivatives |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2286772C Fungicide active substance combinations |
| 06/17/2008 | CA2272291C Crf antagonistic quino- and quinazolines |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/12/2008 | WO2008069609A1 Pyrimidinone derivatives or pyridazinone derivatives for inhibition of factor viia activity |
| 06/12/2008 | WO2008068470A1 Antibacterial polycyclic urea compounds |
| 06/12/2008 | WO2008031556A3 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 06/12/2008 | WO2008015517A3 Ep2 agonists |
| 06/12/2008 | WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139809 Compounds Capable of Activating Cholinergic Receptors |
| 06/12/2008 | US20080139598 e.g. N-(3'-chloro-3-methylbiphenyl-4-yl)-1-(pyrimidin-2-yl)piperidin-4-amine; proline transporter inhibitor; cognition activator; Alzheimer's disease, Attention-Deficit/Hyperactivity Disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, schizophrenia, dementia |
| 06/12/2008 | US20080139590 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 06/12/2008 | US20080139589 2-Methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone; sleep, psychological, nervous system, and attention deficit disorders; drug abuse, alcoholism; antidiabetic agents, cognition activators; Alzheimer's and Parkinson's disease; histamine H3 receptor antagonists |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/12/2008 | US20080139505 Potentiators Of Glutamate Receptors |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | CA2670870A1 Antibacterial polycyclic urea compounds |
| 06/11/2008 | EP1928862A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 06/11/2008 | EP1928857A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 06/11/2008 | EP1928844A2 Bis-aryl amide compounds and methods of use |
| 06/11/2008 | EP1928843A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 06/11/2008 | EP1928842A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 06/11/2008 | EP1928461A1 Pyrimidine compounds as serotonin receptor modulators |
| 06/11/2008 | EP1928242A2 A use of sulfonanilides as herbicide |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | CN101198596A 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases |
| 06/11/2008 | CN101198595A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198590A Novel pyridine derivative and pyrimidine derivative (3) |